CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 31 enrolled
Drug / intervention
Prucalopride +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02425774
NCT02425774Phase 4Completed

Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway: A Potential New Therapeutical Intervention for Postoperative Ileus

KU Leuven·interventional·Posted Apr 24, 2015·Updated Mar 20, 2026

In Brief

A Phase 4 clinical trial evaluating Vagus stimulation, Sham stimulation, and 2 other interventions for Postoperative Ileus. Completed, enrolled 31 participants across 1 site.

Detailed Summary

Hypothesis: Prucalopride can mimic electrical stimulation of the abdominal vagus nerve and has an anti-inflammatory effect. Aims: In the present pilot study, the investigators want to evaluate the anti-inflammatory effect of prucalopride. The following aims are formulated: 1. to show that prucalopride has a similar inflammatory effect as abdominal vagus nerve stimulation (VNS) 2. to evaluate whether prucalopride leads to accelerated post-operative recovery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 24, 2015
Enrollment StartJul 1, 2014
Primary CompletionFeb 27, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.2 years ago

Interventions

Vagus stimulationprocedure

Sham stimulationprocedure

Prucalopridedrug

Placebodrug